Literature DB >> 14614971

The role of T-lymphocyte subpopulations in acute myocardial infarction.

Arnon Blum1, Shay Yeganeh.   

Abstract

T lymphocytes have the potential to affect atherosclerosis at different stages of the process. They play an active role in acute myocardial infarction (AMI) and myocardial damage, and may affect the clinical outcome of patients with coronary artery disease. CD40 ligand expression on T lymphocytes promotes the expression of matrix-degrading enzymes in vascular smooth muscle cells and may thus establish a new pathway of immune-mediated destabilization of the human atheroma. The major class of T lymphocytes present in atherosclerotic lesions is CD4+. CD4+ cells differentiate into Th1 and Th2 lineage in response to the local milieu of cytokines. Much of the emphasis in atherosclerosis research is focused on the role of Th1 type responses.

Entities:  

Year:  2003        PMID: 14614971     DOI: 10.1016/j.ejim.2003.09.002

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  8 in total

1.  Differentiating ischemic from non-ischemic chest pain using white blood cell-surface inflammatory and coagulation markers.

Authors:  Tatyana Levinas; Elizabeth Eshel; Adi Sharabi-Nov; Alon Marmur; Najib Dally
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

Review 2.  Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.

Authors:  Bochra Tourki; Ganesh Halade
Journal:  FASEB J       Date:  2017-06-22       Impact factor: 5.191

3.  LCK: a new biomarker candidate for the early diagnosis of acute myocardial infarction.

Authors:  Fei Xu; Xiao Teng; Xin Yuan; Jiakang Sun; Hengchao Wu; Zhe Zheng; Yue Tang; Shengshou Hu
Journal:  Mol Biol Rep       Date:  2014-09-11       Impact factor: 2.316

Review 4.  Systemic inflammatory response following acute myocardial infarction.

Authors:  Lu Fang; Xiao-Lei Moore; Anthony M Dart; Le-Min Wang
Journal:  J Geriatr Cardiol       Date:  2015-05       Impact factor: 3.327

5.  (Re) Solving Repair After Myocardial Infarction.

Authors:  Giovanna Leoni; Oliver Soehnlein
Journal:  Front Pharmacol       Date:  2018-11-26       Impact factor: 5.810

Review 6.  Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarction.

Authors:  Mira Jung; Michael Dodsworth; Thomas Thum
Journal:  Basic Res Cardiol       Date:  2018-12-06       Impact factor: 17.165

7.  Correlation in gene expression between the aggravation of chronic obstructive pulmonary disease and the occurrence of complications.

Authors:  Yuchen Cai; Runhan Liu; Xinhe Lu; Qiming Zhang; Xinwei Wang; Huijing Lian; Haohua Wang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

Review 8.  HMGB1-Mediated Activation of the Inflammatory-Reparative Response Following Myocardial Infarction.

Authors:  Eleonora Foglio; Laura Pellegrini; Matteo Antonio Russo; Federica Limana
Journal:  Cells       Date:  2022-01-10       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.